01life

Shenzhen, China · Founded 2016 · Privately Held (backing)

Developer of gut microorganisms drugs designed for disease prevention and treatment. 01life is based in Shenzhen, China and was founded in 2016. Its last reported valuation was $182 million in Apr 2023. It has raised $14.5 million.

Last reported valuation
$181.8M
Oct 2026
Priced at
—
Total raised
$14.5M
Last round
—
No prints on record

No secondary trades in 01life shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of 01life with a free account
  • ·Watch 01life: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where 01life prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of 01life stock.

01life Stock Price — Secondary Market Trades | Premier Alternatives